I realise this is pure speculation on my part, but while reading up on the Vaxxas nanopatch recently it dawned on me that they have a collaboration with Merck to develop undisclosed vaccine candidates using the optimisation of the nanopatch delivery. Keeping in mind the relationship between Merck and gardasil and Prof Ian Frazer ... I wonder...
New top 20, page-10
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.35 |
Change
0.040(0.22%) |
Mkt cap ! $352.7M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.13 | $69.15K | 3.766K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 383 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 02/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |